Global Infertility Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Infertility Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Infertility services refer to medical procedures and treatments that are designed to help individuals or couples who are experiencing difficulties in conceiving a child. These services aim to diagnose and treat the underlying causes of infertility, and potentially assist in achieving a successful pregnancy.

According to our (Global Info Research) latest study, the global Infertility Services market size was valued at US$ 7399 million in 2023 and is forecast to a readjusted size of USD 12050 million by 2030 with a CAGR of 7.2% during review period.

The core manufacturers of global infertility services include Ferring Pharmaceuticals, Merck, Jinxin Fertility, Vitrolife, Mayo Clinic and LIVZON. The top three manufacturers account for approximately 24% of the global share. The Asia-Pacific region is the world's largest market, accounting for nearly 45% of the market share.

In terms of product type, assisted reproductive technology (ART) occupies a dominant position, accounting for 62% of the market share. At the same time, in terms of application, females are the largest application field, accounting for 66%.

This report is a detailed and comprehensive analysis for global Infertility Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Infertility Services market size and forecasts, in consumption value ($ Million), 2019-2030

Global Infertility Services market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Infertility Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Infertility Services market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Infertility Services

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Infertility Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ferring Pharmaceuticals, Merck, Jinxin Fertility, Vitrolife, Mayo Clinic, LIVZON, Abbott, Monash IVF, CARE Facility, Theramex, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Infertility Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Infertility Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Assisted Reproductive Technology (ART)
Infertility Drug Services
Others

Market segment by Application
Male
Female

Market segment by players, this report covers
Ferring Pharmaceuticals
Merck
Jinxin Fertility
Vitrolife
Mayo Clinic
LIVZON
Abbott
Monash IVF
CARE Facility
Theramex
TriHealth
NMC Health
CooperSurgical
Irvine Scientific
Virtus Health
CinnaGen
OB GYN Associates
Caerus Biotech
InVitroCare
INVO Bioscience

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Infertility Services product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Infertility Services, with revenue, gross margin, and global market share of Infertility Services from 2019 to 2024.

Chapter 3, the Infertility Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Infertility Services market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Infertility Services.

Chapter 13, to describe Infertility Services research findings and conclusion.